CRISPR THERAPEUTICS AG
77Patents
77Active
77Granted
51Portfolio score
Filing activity: Nov 7, 2016 → Feb 28, 2023
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US10724052B2 | Universal donor cells | Chemistry; Metallurgy | 15 | Active |
| US10865424B2 | Universal donor cells | Chemistry; Metallurgy | 15 | Active |
| US10736919B2 | Materials and methods for engineering cells and uses thereof in immuno-oncology | Chemistry; Metallurgy | 10 | Active |
| US10857184B2 | Materials and methods for engineering cells and uses thereof in immuno-oncology | Chemistry; Metallurgy | 8 | Active |
| US11008586B2 | Universal donor cells | Chemistry; Metallurgy | 7 | Active |
| US11166985B2 | Materials and methods for engineering cells and uses thereof in immuno-oncology | Chemistry; Metallurgy | 7 | Active |
| US10881689B2 | Materials and methods for engineering cells and uses thereof in immuno-oncology | Chemistry; Metallurgy | 6 | Active |
| US10729725B2 | Materials and methods for engineering cells and uses thereof in immuno-oncology | Chemistry; Metallurgy | 6 | Active |
| US11118195B2 | Universal donor cells | Chemistry; Metallurgy | 6 | Active |
| US11008587B2 | Universal donor cells | Chemistry; Metallurgy | 6 | Active |
| US11116797B2 | Universal donor cells | Chemistry; Metallurgy | 6 | Active |
| US11071755B1 | Materials and methods for engineering cells and uses thereof in immuno-oncology | Chemistry; Metallurgy | 6 | Active |
| US11559588B2 | Materials and methods for treatment of Spinocerebellar Ataxia Type 1 (SCA1) and other Spinocerebellar Ataxia Type 1 Protein (ATXN1) gene related conditions or disorders | Chemistry; Metallurgy | 6 | Active |
| US11104918B2 | Universal donor cells | Chemistry; Metallurgy | 5 | Active |
| US11118196B2 | Universal donor cells | Chemistry; Metallurgy | 5 | Active |
| US11254912B2 | Methods and compositions for treating cancer | Chemistry; Metallurgy | 5 | Active |
| US11135247B2 | Materials and methods for engineering cells and uses thereof in immuno-oncology | Chemistry; Metallurgy | 5 | Active |
| US11191783B2 | Materials and methods for engineering cells and uses thereof in immuno-oncology | Chemistry; Metallurgy | 5 | Active |
| US11566230B2 | Universal donor cells | Chemistry; Metallurgy | 3 | Active |
| US11433103B2 | Universal donor cells | Chemistry; Metallurgy | 3 | Active |
| US11180776B1 | Universal donor cells | Chemistry; Metallurgy | 3 | Active |
| US11578309B2 | Universal donor cells | Chemistry; Metallurgy | 3 | Active |
| US11013767B2 | Materials and methods for engineering cells and uses thereof in immuno-oncology | Chemistry; Metallurgy | 3 | Active |
| US11434505B2 | Universal donor cells | Chemistry; Metallurgy | 3 | Active |
| US11649438B2 | Methods and compositions for treating cancer | Chemistry; Metallurgy | 2 | Active |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.